Home › Funds › Logos Global Management LP › CLDX

Logos Global Management LP position in CLDX

CELLDEX THERAPEUTICS INC NEW · Health Care

Logos Global Management LP reported holding 2,100,000 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q2 2026 13F filing — a position valued at US$78.1M, representing 3.36% of its reported portfolio and ranking #9 among its reported holdings. Logos Global Management LP has disclosed CLDX holdings in 6 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)2.10M sh
Reported value held$78.14M
Portfolio Weight3.36%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's CLDX position evolved

Logos Global Management LP first disclosed a stake in CLDX in Q1 2024 at 650,000 shares (US$27.3M). The position peaked in Q2 2026 at 2,100,000 shares, worth US$78.1M. Across 6 filings, Logos Global Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,100,000 shares valued at US$78.1M — an increase of 1,650,000 shares quarter over quarter.. Notable position changes include a 29% increase in Q1 2026 (shares rose 17% over the following quarter), a 367% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 650.00K $27.28M New
Q3 2024 900.00K $30.59M New
Q2 2025 600.00K $12.21M New
Q4 2025 350.00K $9.51M New
Q1 2026 450.00K $14.27M Add
Q2 2026 2.10M $78.14M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLDX and 13F data

CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 43 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Eversept Partners, LP (US$66.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLDX

All CLDX fund holders →

FAQ

How long has Logos Global Management LP held CLDX?

Logos Global Management LP has disclosed CLDX holdings in 6 of the last 10 reported quarters, going back to Q1 2024.

What is Logos Global Management LP's current position in CLDX?

As of Q2 2026, Logos Global Management LP holds 2.10M shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $78.14M, representing 3.36% of its reported portfolio and ranking #9.

Has Logos Global Management LP been buying or selling CLDX?

In the latest 13F filing (Q2 2026), Logos Global Management LP increased its position in CLDX. The position peaked in Q2 2026 at 2.10M shares.

Which other funds hold CLDX?

Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Eversept Partners, LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.